Asking young people to complete a survey on a tablet before visiting a mental health professional more than doubled the number of people identified at risk of psychosis.
Researchers at University of California San Diego School of Medicine, Sanford Stem Cell Institute and Moores Cancer Center report that a late-stage, pre-clinical small molecule inhibitor, called rebecsinib, reverses malignant hyper-editing by an inflammation-induced protein isoform, known as ADAR1...
The UC Davis pediatric nephrology team launched an initiative this month to help preserve the veins of children with chronic and end-stage kidney disease.
Engaging specific serotonin receptors inside neurons promotes the growth of new connections, according to a new study. The findings will help guide efforts to discover new drugs for depression, PTSD and other disorders.
In cancer stem cell and animal models, a late-stage, pre-clinical small molecule inhibitor called rebecsinib, reversed overactive protein splicing of ADAR1 protein that drives cloning capacity and immune evasion by many malignancies.
